Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2022. Start Trial.
Date Value
October 08, 2026 5.64
October 07, 2026 6.16
October 06, 2026 6.06
October 05, 2026 6.19
October 02, 2026 6.055
October 01, 2026 6.145
September 30, 2026 6.56
September 29, 2026 6.88
September 28, 2026 7.41
September 25, 2026 7.93
September 24, 2026 7.83
September 23, 2026 7.94
September 22, 2026 8.555
September 21, 2026 7.70
September 18, 2026 9.43
September 17, 2026 8.75
September 16, 2026 5.35
September 15, 2026 6.36
September 14, 2026 7.93
September 11, 2026 7.95
September 10, 2026 9.39
September 09, 2026 10.50
September 08, 2026 8.93
September 04, 2026 15.27
September 03, 2026 12.78
Date Value
September 02, 2026 9.75
September 01, 2026 6.59
August 31, 2026 4.56
August 28, 2026 4.87
August 27, 2026 5.06
August 26, 2026 5.09
August 25, 2026 5.19
August 24, 2026 5.82
August 21, 2026 6.00
August 20, 2026 6.002
August 19, 2026 6.135
August 18, 2026 7.100
August 17, 2026 5.88
August 14, 2026 6.032
August 13, 2026 5.745
August 12, 2026 7.090
August 11, 2026 7.29
August 10, 2026 7.35
August 07, 2026 7.65
August 06, 2026 7.946
August 05, 2026 7.947
August 04, 2026 8.256
August 03, 2026 8.961
July 31, 2026 9.411
July 30, 2026 9.666

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Veracyte, Inc. 43.60
Quantum Cyber NV 1.39
MediciNova, Inc. 1.54
ADMA Biologics, Inc. 10.33
ACADIA Pharmaceuticals, Inc. 19.58